
Browsing restrictions can be lifted for a fee.
The latest data point for RXRX's EV/EBITDA ratio in Q1'26 stands at -8.12, indicating a significant deterioration from the previous quarter's -2.45 and reflecting heightened valuation pressures relative to earnings before interest, taxes, depreciation, and amortization. Over the period from Q2'23 to Q1'26, the EV/EBITDA ratio has exhibited persistent negativity, starting at -9.02 and fluctuating between -9.39 in Q4'23 and a relative improvement to -2.45 in Q4'25, before the sharp decline in Q1'26. This area chart trend highlights overall volatility with a general stabilization in negative territory during 2024-2025, suggesting operational challenges or market skepticism, though no positive values emerge, underscoring RXRX's unprofitability in EBITDA terms.